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CeOBJECTIVES The aim of this study was to determine if hyperpolarized [1,4–13C2]malate imaging could measure
cardiomyocyte necrosis after myocardial infarction (MI).
BACKGROUND MI is deﬁned by an acute burst of cellular necrosis and the subsequent cascade of structural and
functional adaptations. Quantifying necrosis in the clinic after MI remains challenging. Magnetic resonance-based
detection of the conversion of hyperpolarized [1,4–13C2]fumarate to [1,4–13C2]malate, enabled by disrupted cell
membrane integrity, has measured cellular necrosis in vivo in other tissue types. Our aim was to determine whether
hyperpolarized [1,4–13C2]malate imaging could measure necrosis after MI.
METHODS Isolated perfused hearts were given hyperpolarized [1,4–13C2]fumarate at baseline, immediately after
20 min of ischemia, and after 45 min of reperfusion. Magnetic resonance spectroscopy measured conversion into
[1,4–13C2]malate. Left ventricular function and energetics were monitored throughout the protocol, buffer samples were
collected and hearts were preserved for further analyses. For in vivo studies, magnetic resonance spectroscopy and a
novel spatial-spectral magnetic resonance imaging sequence were implemented to assess cardiomyocyte necrosis in rats,
1 day and 1 week after cryo-induced MI.
RESULTS In isolated hearts, [1,4–13C2]malate production became apparent after 45 min of reperfusion, and increased
2.7-fold compared with baseline. Expression of dicarboxylic acid transporter genes were negligible in healthy and
reperfused hearts, and lactate dehydrogenase release and infarct size were signiﬁcantly increased in reperfused hearts.
Nonlinear regression revealed that [1,4–13C2]malate production was induced when adenosine triphosphate was depleted
by >50%, below 5.3 mmol/l (R2 ¼ 0.904). In vivo, the quantity of [1,4–13C2]malate visible increased 82-fold over
controls 1 day after infarction, maintaining a 31-fold increase 7 days post-infarct. [1,4–13C2]Malate could be resolved using
hyperpolarized magnetic resonance imaging in the infarct region one day after MI; [1,4–13C2]malate was not visible in
control hearts.
CONCLUSIONS Malate production in the infarcted heart appears to provide a speciﬁc probe of necrosis acutely after MI,
and for at least 1 week afterward. This technique could offer an alternative noninvasive method to measure cellular
necrosis in heart disease, and warrants further investigation in patients. (J Am Coll Cardiol Img 2018;11:1594–606)
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1595AB BR E V I A T I O N S
AND ACRONYM S
ATP = adenosine triphosphate
CVD = cardiovascular disease
LDH = lactate dehydrogenase
MI = myocardial infarction
MRI = magnetic resonance
imaging
mRNA = messenger
ribonucleic acid
MRS = magnetic resonance
spectroscopy
PCr = phosphocreatineC ell death is a hallmark of cardiovascular dis-ease (CVD), including heart failure andmyocardial infarction (MI). Cardiomyocytes
die via distinct mechanisms—necrosis, apoptosis, and
autophagy—each of which occurs by different
signaling events (1). Necrosis is marked by distinct
morphologic changes, including cell and organelle
swelling, plasma membrane rupture, and depletion
of chemical energy in the form of adenosine triphos-
phate (ATP) (1,2). Emerging evidence suggests that
instead of being a passive form of cell death,
necrosis can be regulated by signaling cascades (1,2).
Experimentally, abrogating necrosis improves myo-
cardial outcome (3–7).SEE PAGE 1607
SNR = signal to noise ratioIn vivo imaging of necrosis in the clinic remains
challenging. Myocardial necrosis associated with
ischemia and reperfusion is detected clinically by the
presence of cardiomyocyte-speciﬁc proteins released
into the circulation, ideally troponin. However,
circulating troponin assays are not speciﬁc to MI,
particularly in the settings of renal failure or sepsis
(8). Furthermore, biomarkers found in the blood do
not enable spatial localization, preventing tissue
damage from being assigned to regions of the heart.
Imaging-based techniques, including echocardiogra-
phy, nuclear imaging, and magnetic resonance im-
aging (MRI) with and without late gadolinium
enhancement, are useful in detecting the outcomes
associated with necrosis and other cell death, namely,
reduced perfusion, local wall motion abnormalities,
wall thinning, edema, and scar development (9–15).
Invasive myocardial analysis techniques, including
histology, focus on regions of tissue in which cell
death causes scar formation (2,16–19).
Recently, the metabolic production of [1,4-13C2]
malate from hyperpolarized [1,4-13C2]fumarate was
demonstrated to offer positive MR contrast to iden-
tify cellular necrosis in vivo in tumor cells and acute
kidney injury (20,21). The fumarate-to-malate hy-
dration reaction is catalyzed by the intracellular
enzyme fumarase as part of the tricarboxylic acid
cycle. Unlike many metabolic reactions requiring co-
factors such as nicotinamide adenine dinucleotide to
proceed, the fumarase reaction requires no cofactors
and maintains activity during cell death (21). Imagingand Cancer Research UK. Dr. Gallagher has received research funding from G
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Manuscript received January 15, 2017; revised manuscript received Septembmalate using 13C MRI ensured speciﬁcity to
necrosis by targeting loss of cell membrane
integrity: [1,4-13C2]malate production was
only observed when the cell membrane was
disrupted, enabling the infused hyper-
polarized [1,4-13C2]fumarate to access the
fumarase enzyme (21).
Malate imaging may be valuable to detect
necrosis in heart disease. A dicarboxylic acid
transporter with a known capacity to import
fumarate into cells has not been detected in
the heart (22,23), implying that malate pro-
duction may only be observed due to cell
membrane rupture. Furthermore, the clinical
translation of hyperpolarized [1,4-13C2]fuma-
rate is actively underway and hyperpolarized [1-13C]
pyruvate is already being used in humans (24,25).
Noninvasive [1,4-13C2]malate imaging should soon be
available for patients.
This study tested the hypothesis that MRI of
[1,4-13C2]malate production could assess the acute
burst of cardiomyocyte necrosis characteristic of a MI.
Initially, we used the isolated perfused heart to ach-
ieve this aim, to conﬁrm the speciﬁcity of [1,4-13C2]
malate detection to cell membrane rupture. We then
translated the hyperpolarized [1,4-13C2]fumarate
method in vivo, assessing myocardial [1,4-13C2]malate
production at multiple time points after infarction
and developing a novel MRI pulse sequence to image
[1,4-13C2]malate with high sensitivity. Our results
demonstrate the potential of hyperpolarized
[1,4-13C2]malate imaging to enhance our understand-
ing of the mechanisms driving myocardial necrosis,
and to image areas of necrosing myocardium.
METHODS
All experiments were performed in accordance with
relevant UK/Danish legislation and were subject to
local ethical review. An overview of the experimental
protocol is provided in Figure 1. Further experimental
details are available in the Online Appendix.
CONTRAST AGENT PREPARATION. [1,4-13C2]
Fumaric acid was prepared and hyperpolarized as
described previously (21). [1,4-13C2]Fumarate was
diluted in the perfusion buffer to 1 mmol/l forE Healthcare and GlaxoSmithKline. All other authors
s paper to disclose. *Drs. Miller and Lau contributed
ontributed equally to this work and are joint senior
er 19, 2017, accepted September 21, 2017.
FIGURE 1 Overview of the Experimental Protocol
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(A) Protocol for the isolated perfused heart experiments. After a stabilization period,
hearts were assessed with carbon-13 (orange) and phosphorus-31 (blue) MRS at base-
line, immediately after a 20-min period of total global ischemia, and after 45 min of
reperfusion. Buffer samples were collected for LDH measurements (green). After the
ﬁnal carbon-13 scan, hearts were freeze-clamped for subsequent messenger RNA an-
alyses. (B) In vivo experimental protocol. Carbon-13 MRS and MRI experiments were
performed 1 day after cryo-induction of MI. MRS experiments were repeated after 7 days.
LDH ¼ lactate dehydrogenase; MI ¼ myocardial infarction; MRI ¼ magnetic resonance
imaging; MRS ¼ magnetic resonance spectroscopy.
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1596perfused heart experiments, and 2 ml of 20 mmol/l
[1,4-13C2]fumarate was infused in vivo over 10 s.
PERFUSED HEART EXPERIMENTS. Hearts from male
Wistar rats (w300 g; n ¼ 6) were perfused in the
Langendorff mode as described previously (26) and as
detailed in the Online Appendix. Carbon-13 and
phosphorus-31 MR spectra were acquired alternately
throughout the protocol. Buffer samples were
collected to measure lactate dehydrogenase (LDH)
release from necrosing cells, and hearts were freeze-
clamped and stored at 80C for messenger ribonu-
cleic acid (mRNA) analysis. An additional cohort of 7
hearts were reperfused to enable quantiﬁcation of
infarct area due to necrosis histologically using
2,3,5-triphhenyltetrazoliumchloride (27,28) (Online
Appendix).
IN VIVO MAGNETIC RESONANCE. Six female Wistar
rats (mass z200 g; Envigo, Huntingdon, United
Kingdom) were divided into 2 groups (cryo-induced
MI or control; n ¼ 3 each). Animal handling was per-
formed as described in the Online Appendix.
Carbon-13 magnetic resonance spectroscopy. Experi-
ments were performed as described in the Online
Appendix, using a 72-mm dual-tuned 1H/13C proton/
carbon birdcage volume coil (Rapid Biomedical
GMBH, Rimpar, Germany) (29).Carbon-13 MRI. A novel minimum phase multiband
spatial-spectral radiofrequency excitation pulse was
designed to simultaneously excite [1,4-13C2]fumarate
with a 4 ﬂip angle, and both malate resonances with
a 20 ﬂip angle, with a chosen slice thickness of 20
mm. The pulse sequence developed is detailed in
Figure 2 and the Online Appendix.
Proton images corresponding with the middle of
the hyperpolarized imaging slice were acquired by
CINE-MRI (29,30). To quantify visually detected re-
gions of akinesia, multidimensional feature tracking
analysis was performed on CINE datasets using cmr42
(Circle, Calgary, Canada), and the long axis longitu-
dinal and short axis circumferential myocardial strain
calculated (31). Analyses of MR data are detailed in
the Online Appendix.
STATISTICAL ANALYSIS. Statistical analyses were
performed using GraphPad Prism. Perfused heart data
were compared using the paired, nonparametric
Friedman test, with the Dunn’s test implemented for
post hoc multiple comparisons. Segmental linear
regression was applied to investigate the relationship
between energetics and malate production, ﬁtting to
slope values, the x-intercept, and the value x0 that
signiﬁed the threshold for reduced ATP level that
permitted cellular necrosis to proceed. Differences
between groups in vivo were assessed by an unequal
variance (Welch’s) t test with the Holm-Sidak post
hoc correction for multiple comparisons. Statistical
signiﬁcance was considered at p < 0.05. Quoted
statistics are mean  SE of the mean.
RESULTS
CARDIOMYOCYTE FUMARATE UPTAKE IS NEGLIGIBLE.
To examine bulk fumarate uptake into the healthy
myocardium we infused hyperpolarized [1,4-13C2]
fumarate into the perfused heart and used magnetic
resonance spectroscopy (MRS) to search for evidence
of its enzymatic conversion into other species.
Extremely low levels of metabolism were detected
(Online Figure S1A). As an additional test, we
measured mRNA expression of putative fumarate
transporters in control heart tissue and tissue
collected from hearts 45 min after reperfusion. Online
Figure S1B shows that the genes encoding each
transporter were detected robustly in kidney tissue
(Slc3a2 and Slc3a3, relative to internal control 18s).
The mRNA from Slc3a2 could not be detected in heart
tissue. Expression of Slc3a3 was approximately 4 or-
ders of magnitude lower than in the kidney, for both
healthy and reperfused tissue (kidney, 4.1  106 
1.5  106; healthy heart, 4.2  1010  2.7  1010;
reperfused heart, 1.4  109  3.7  1010).
FIGURE 2 Magnetic Resonance Imaging Pulse Sequence Implemented to Achieve In Vivo Cardiac Malate Imaging
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(A and B) Multiband spectral-spatial excitation with spiral IDEAL multi-echo readout, showing both radiofrequency (A) and read/phase/slice
gradient trajectories (B). The corresponding frequency proﬁle produced by the pulse (C) corresponds with a ﬂip angle ofw4 on the fumarate
resonance, and approximately 20 on both malate peaks.
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1598REPERFUSION COMPROMISES CELL MEMBRANE
INTEGRITY IN THE PERFUSED HEART. Hemodynamics
resulting from our ischemia-reperfusion protocol are
shown in the Online Appendix.
Upon infusion into the healthy heart, hyper-
polarized [1,4-13C2]fumarate showed negligible con-
version into [1,4-13C2]malate (Figure 3A). Immediately
upon reperfusion, [1,4-13C2]malate was visible in some
hearts, yet upon quantiﬁcation the malate/fumarate
ratio was not signiﬁcantly increased (Figure 3C). Upon
45 min of reperfusion, a robust [1,4-13C2]malate signal
was obvious in all hearts, and the malate/fumarate
ratio increased 2.7-fold over baseline values.
MRS measurements of [1,4-13C2]malate production
were compared with LDH release into the buffer
and 2,3,5-triphhenyltetrazoliumchloride-staining for
infarct area, historically gold standard markers for
necrosis (32). In healthy hearts, buffer LDH activity
was 0.71  0.09 mU/ml. After 2 min of reperfusion,
a time point that correlated with the MRS results,
LDH activity was unchanged (1.0  0.3 mU/ml).
The LDH measurements during the reperfusion
period showed a gradual upward trend in buffer
LDH activity (Figure 3B). The LDH activity was
increased signiﬁcantly by 3.6-fold at the ﬁnal
time point (2.6  0.4 mU/ml). In addition, 2,3,5-
Triphhenyltetrazoliumchloride revealed that 2.2 
0.6% of the left ventricle of healthy isolated perfused
hearts showed signs of necrosis. After ischemic injury
and 2 h of reperfusion, 26.0  2.5% of the left
ventricle of the perfused hearts were necrotic, an
increase of 11.8-fold.
NECROSIS CORRELATES WITH MYOCARDIAL
ENERGETICS. In healthy hearts, the phosphocreatine
(PCr)/ATP ratio was measured to be 1.6  0.1, from
which we calculated [PCr] ¼ 16.5  1.4 mmol/l. During
ischemia, [PCr] was depleted to 1.59  0.29 mmol/l,
whereas [ATP] was not signiﬁcantly reduced ([ATP] ¼
6.00  0.29 mmol/l). After 45 min of reperfusion,
[PCr] recovered to baseline values, yet [ATP] was
depleted by 67% to 3.48  0.46 mmol/l. Figure 4
summarizes these data.
Because ATP depletion has been implicated as an
initiating event of necrosis, we examined the corre-
lation between [ATP] (at all 13C examination points)
and [1,4-13C2]malate production. The relationship
(Figure 4C) showed a “thresholding” pattern, in which
very little [1,4-13C2]malate production was observed
when myocardial [ATP] was above 5.3 mmol/l (a 50%
decrease), but when [ATP] dropped below this value,
small changes to [ATP] enabled substantial changes
to [1,4-13C2]malate. Segmental linear regression
(R2 ¼ 0.902) revealed that when myocardial [ATP] wasmaintained above 5.3 mmol/l, the slope was 0.065
mmol/l1 (ATP depletion by 1 mmol/l caused a 6%
increase in malate), whereas when [ATP] was below
5.3 mmol/l, each unit change in [ATP] resulted in a
74% increase in [1,4-13C2]malate.
IN VIVO HYPERPOLARIZED 13C-FUMARATE MR. The
quantity of [1,4-13C2]malate visible in the in vivo
infarcted heart was signiﬁcantly different among all 3
groups measured (Figure 5). The mean malate/fuma-
rate ratio was 0.21  0.03 1 day post infarction and
decreased to 0.077  0.005 7 days post infarction,
compared with 0.0025  0.001 in control animals.
This striking w82-fold increase in visible malate
signal post infarction corresponds to an estimated
standardized effect size of approximately 5 (Cohen’s
d, a scale-independent quantitative measure of effect
strength, deﬁned as the difference in means upon
the SD) (33). The increased malate signal 1 day post
infarction enabled the use of the spectral-spatial im-
aging sequence to spatially resolve the region of
malate production (Figure 6). The region co-localized
with an observed region of akinesia detected using
CINE-MRI and quantiﬁed by computation of peak
longitudinal and circumferential myocardial strain
(Figure 7). It was not possible to resolve any regions of
malate production in animals subject to sham surgery
alone.
DISCUSSION
This study demonstrated that hyperpolarized
[1,4-13C2]fumarate can be used with MR to identify
regions of cardiomyocyte necrosis. Detection of ne-
crosis was possible 1 day after MI, where an 82-fold
increase in [1,4-13C2]malate production was
observed, and up to 1 week later, when [1,4-13C2]ma-
late production remained elevated by 31-fold over
baseline. MR detection of the hyperpolarized
[1,4-13C2]fumarate to [1,4-13C2]malate conversion of-
fers the ﬁrst method to noninvasively measure the
rate and location of cardiomyocyte necrosis.
SPECIFICITY TO NECROSIS. The gold standard
method for detecting cellular necrosis is by observing
loss of membrane integrity via assays for uptake of
dyes such as propidium iodide or the release of pro-
teins such as troponin or LDH. Hyperpolarized malate
MRI extends this concept into the realm of molecular
imaging. The metabolic tracer hyperpolarized
[1,4-13C2]fumarate is converted to [1,4-13C2]malate in
the presence of fumarase only (21). In healthy tissue,
fumarase is located intracellularly, making it inac-
cessible to intravenous [1,4-13C2]fumarate. However,
with the early events of necrosis, fumarase is released
FIGURE 3 Comparison Between 2 Necrosis Measurements, 13C-Malate Spectroscopic Detection and LDH Release Into the Buffer,
in Perfused Hearts
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(A) Representative MRS data from 1 perfused heart. (B) Average LDH release into the buffer throughout the experimental protocol, measured in
4hearts.As inmalateMRS, a trend toward increasedbufferLDHactivitywasobserved 2minafter reperfusion, but it didnot reach signiﬁcance until
45 min of reperfusion. (C) Quantiﬁcation of 13C-malate detection across 6 hearts. (D) Quantiﬁcation of LDH release at time points mirroring MRS
data. (E)Necrotic region of the left ventricle (LV), expressed as a percentage, at the healthy time point, and after 2 h of reperfusion (when 2,3,5-
triphhenyltetrazoliumchloride-staining can ﬁrst reveal the necrotic region reliably [27,28]). As with malate MRS and LDH release, a signiﬁcant
increase in necrosis was observed after late reperfusion (Ei). The degree of increase was larger (w12) due to ongoing necrosis during the
reperfusion period (27). Representative triphhenyltetrazoliumchloride-stained heart slices are shown to the right (Eii). *p< 0.05 compared with
healthy group. Abbreviations as in Figure 1.
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FIGURE 4 Quantiﬁcation of High-Energy Phosphate Content of Perfused Hearts Throughout the Experimental Protocol
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Pseudoquantiﬁcation of the [ATP] and [PCr] was performed by assuming that the [ATP] in baseline healthy hearts was 10.6 mmol/l in the fully
relaxed 10-min acquisition. All spectra were referenced to this initial spectrum. Each parameter was measured from the spectra acquired over
the ﬁnal 5 min of the baseline period, of ischemia, and of reperfusion, respectively. (A) When averaged across the group of hearts, PCr was
signiﬁcantly reduced during ischemia and recovered after 45 min of reperfusion. (B) ATP was maintained throughout the ischemic period, but
was depleted after 45 min of reperfusion. (C) Regression analysis revealed that [ATP] has a segmental relationship with 13C-malate
production (expressed as malate/fumarate relative to the equivalent baseline value). When [ATP] was maintained above 5.3 mmol/l, very low
levels of 13C-malate production were observed. Below this [ATP] threshold, each unit of [ATP] depletion (in mmol/l) resulted in a 74% increase
in 13C-malate production. *p < 0.05 compared with healthy group. ATP ¼ adenosine triphosphate; PCr ¼ phosphocreatine.
Miller et al. J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 1 1 , N O . 1 1 , 2 0 1 8
Hyperpolarized MR Assessment of Necrosis N O V E M B E R 2 0 1 8 : 1 5 9 4 – 6 0 6
1600into the extracellular space and can interact with
infused [1,4-13C2]fumarate, to yield hyperpolarized
[1,4-13C2]malate at a level that depends on the
amount of released fumarase (21).
This study has generated evidence suggesting that,
in cardiomyocytes, hyperpolarized [1,4-13C2]fumarate
uptake and thus [1,4-13C2]malate production is near
exclusively enabled by loss of membrane integrity.
Our results conﬁrmed that mRNA from the trans-
porter encoded by Slc3a3 was detected at a very low
level (22,23). Furthermore, given rapid ongoing rates
of fumarate metabolism in cardiomyocytes, the lackof [1,4-13C2]malate production in healthy hearts
strongly suggests negligible uptake.
NECROSIS, ENERGETICS, AND CONTRACTILE
FUNCTION IN ISCHEMIC HEART DISEASE. During
ischemia, acidosis reduces cardiac contractile func-
tion and minimizes ATP demand (34). During reper-
fusion, the heart’s contractile apparatus restarts and
ion balance must be restored. In this study, 31P MRS
measured preserved [ATP] immediately after
ischemia alongside negligible levels of necrosis. After
45 min of reperfusion, ATP levels were reduced by
67% (below the threshold of 50% depletion suggested
FIGURE 5 In Vivo 13C-Malate MR Detected the Acute Burst of Necrosis 24 h After Ischemia-Reperfusion Injury, as Well as After 1 Week
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(A) Example hyperpolarized [1,4-13C]fumarate spectra acquired from (Ai) control rats, or (Aii) 1 or (Aiii) 7 days post MI; spectra shown are
temporally summed over 60 s after injection of fumarate. Spectra are shown normalized to the fumarate peak, and the quantity of visible
[1,4-13C]malate produced is signiﬁcantly different among all 3 groups (B), with an approximately 82-fold increase in the total ([1-13C]þ[4-13C])
malate/fumarate 1 day post infarction compared with matched controls. For the 3 illustrative in vivo spectra shown, this ratio is 0.0035
(control), 0.1950 (day 1), and 0.0720 (day 7). *p < 0.05 compared with healthy group. HP ¼ hyperpolarized; MI ¼ myocardial infarction;
MR ¼ magnetic resonance; TP ¼ thermally polarized.
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FIGURE 6 Spiral Multiband Pulse Sequence Developed Resolved Hyperpolarized [1,4-13C2]Fumarate Perfusing the Heart in Both Control
and Infarcted Animals, 1 Day After Infarction
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[1,4-13C2]malate production was only visible in infarcted animals, and was localized to the anterior region of the chest wall, consistent with
the location of the insult. The color axis is linear for the 4 hyperpolarized datasets, with the maximum level scaled down by the factor shown.
Proton underlay images have been subject to a gamma correction (g ¼ 12) to improve visualization of the cardiac structures.
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1602by our data), and histology, LDH release into perfu-
sion buffer and malate MRS suggested increased ne-
crosis. In general, the sudden elevation in ATP
demand during reperfusion may be a fundamental
contributor to reperfusion injury, exacerbating ATP
depletion and ultimately permitting necrotic cell
death (34).
Our data agree with numerous studies demon-
strating a permissive role for ATP levels and irre-
versible myocardial damage (16,17,19,35). However,
the permissive value identiﬁed by our data was twice
as high as that from previous work (19,35). Addition-
ally, our results diverge from previous work by sug-
gesting a weak correlation between necrosis and ATP,
and a stronger relationship between necrosis and
lactate (19). The differences may be explained bydifferences in ATP demand, and the difference in
parameters representing “necrosis” that were
measured. Our study targeted a fundamental event of
necrosis—cell membrane rupture—as an output,
whereas previous work relied on scar size (19,36).
Scar may encompass other mechanisms of cell dam-
age beyond necrosis that cloud the strength of the
ATP–necrosis relationship (apoptosis, for example,
requires ATP to proceed) (1). In cerebral infarction,
experimental work has implicated tissue lactate as a
predictor of destruction of the tissue at risk (37),
whereas regions of ATP depletion pinpoint necrotic
core (37). Future work with hyperpolarized [1-13C]
pyruvate (to measure [1-13C]lactate production)
alongside [1,4-13C2]fumarate and phosphorus-31 MRS
may clarify if noninvasive metabolic biomarkers can
FIGURE 7 Peak Longitudinal and Circumferential Short Axis Myocardial Strain
LAX LV Strain SAX LV Strain HP 13 C[1+4]MalateA B C
(A) Peak longitudinal long axis and (B) circumferential short axis myocardial strain 1 day after infarction as calculated via a feature-tracking
algorithm and the acquired CINE datasets. The region of anomalous strain is consistent with the applied position of the cryo-probe on the
proximal surface of the heart, and co-localizes with the region of visible hyperpolarized malate signal as obtained in the hyperpolarized
experiment (C) depicted in Figure 6, together with its slice location as shown in (A). HP ¼ hyperpolarized; LAX ¼ long axis; LV ¼ left
ventricle; SAX ¼ short axis.
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1603provide similar predictive information to help guide
therapy after MI.
The delay to cardiomyocyte necrosis resulting from
MI lengthens the treatment window into the early
reperfusion period for therapies that abrogate necro-
sis. Our results, in combination with the literature,
suggest that necrotic cell death continues to increase
up to 24 h after an MI. Pharmacological or mechanical
blockade of programmed necrosis (e.g., by remote
ischemic conditioning) at any point before this time
could preserve myocardial viability (34,38). Our data
suggest that an approach to abrogating car-
diomyocyte necrosis could involve maintaining [ATP]
during reperfusion, by supporting its production or
delaying the restoration of its use (39,40). Further
work is warranted to characterize energetic treatment
strategies in the context of this treatment window.
IN VIVO MALATE IMAGING. To interpret the results
of a hyperpolarized [1,4-13C2]fumarate scan in the
context of CVD, the implications of choosing an MRS
or MRI acquisition must be understood. All values
reported herein were quantiﬁed spectroscopically,
averaging the 13C signal over the cardiac volume. This
was optimal for the perfused heart, in which the mild,
global insult caused diffuse cell death, as visualized
by histology, and perfusion was maintained. How-
ever, MI causes localized cell death, leaving adjacent
and remote tissue viable and potentially affecting
regional perfusion. As such, the 82-fold increase inmalate/fumarate averaged an intense focal region of
cell death with regions of intact cardiomyocytes, and
assumed that whole-heart perfusion was maintained.
To observe necrosis within the damaged tissue
volume, [1,4-13C2]malate MRI with high spatial reso-
lution was required.
We developed and demonstrated a novel cardiac-
gated sequence applied to free breathing animals
in vivo, to sensitively detect spatially resolved
malate production (and thus necrosis). The hybrid
multiband spatial-spectral radiofrequency excitation
pulse proposed forms a compromise between con-
ventional chemical shift imaging MR sequences,
which necessitate a long acquisition time, and the
use of single-band spectral-spatial excitation pulses,
which necessitate potentially unrealistically strong
gradients for high-resolution imaging. In the context
of hyperpolarized fumarate, the spectral-spatial
approach is additionally challenging due to the close
spectral separation of the malate doublet, which
would necessitate a temporally long excitation
pulse with a rapid imaging readout, leading to a
comparative reduction in image domain signal to
noise ratio (SNR). The sequence proposed, therefore,
preserves longitudinal magnetization in the injected
hyperpolarized fumarate without unduly sacriﬁcing
excitation time (and therefore SNR) while exciting
any evolved malate present at a low concentration
with a ﬂip angle that is large enough for it to be
detectable. The comparatively short duration of the
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1604signal-efﬁcient readout trajectory used maximizes
the SNR, and minimizes the effect of blurring due to
motion. We note that the observed malate signal was
primarily localized to the anterior wall of the
myocardium, consistent with the central location of
the infarct as inferred through feature tracking tech-
niques. This ﬁnding is consistent with the hypothesis
that the central region is highly necrotic, although
further work will quantitatively correct for the
nonuniform sensitivity proﬁle of the receive array
coil used in this study preventing undue weighting
toward the chest wall, either via data-driven methods
(if the data has sufﬁcient SNR) or through the use of
ﬁducial markers and electrodynamic calculations
(in case of low SNR) (41). We expect future studies
could quantitatively compare this region of malate
with other MR markers of tissue injury, such as late
gadolinium enhancement.
TRANSLATIONAL OUTLOOK. Hyperpolarized MR
using [1-13C]pyruvate has been used in patients
(24,25). Translation of 13C-fumarate into the clinic has
funding and is underway, implying that it will be the
next tracer used clinically and making this study
important for its imminent application in human
CVD. The malate imaging sequence developed here is
eminently translatable for future application in
humans; scaling arguments predict that it would
function with comparable anatomic resolution with
greater SNR, and could be simpliﬁed to achieve
malate imaging in other organs in which cardiac and
respiratory motion do not present the same chal-
lenge. Spatially resolved hyperpolarized malate MRI
could have a role in determining myocardial viability
acutely in MI or to identify ongoing, low-grade car-
diomyocyte drop-out that drives cardiac remodeling
into heart failure that may not be detectable by
bloodborne biomarkers. In addition, when applied
in patients with chronic ischemia/angina, hyper-
polarized malate MRI may prove valuable to evaluate
the functional consequences of coronary artery
disease or other vascular dysfunction and guide
treatment decisions (42). Furthermore, malate imag-
ing may be useful to identify and evaluate novel
therapies that protect cardiomyocyte viability by
abrogating cellular necrosis. Well-established ap-
proaches including rest and stress absolute myocar-
dial blood ﬂow with positron emission tomography
or fractional ﬂow reserve studies with computed
tomography scans and coronary angiography
are integrated in clinical practice for evaluation
of epicardial coronary artery disease (15,43), andhyperpolarized 13C-fumarate MRI may add to the
physiological understanding of microvascular
dysfunction. However, until 13C-fumarate MRI is
investigated in human studies, its translational
potential in this area remains speculative.
STUDY LIMITATIONS. Hyperpolarized 13C-fumarate
will require several years of active development
before it becomes available for patients. In the
meantime, mechanistic work to characterize
the relationships between necrosis, hyperpolarized
13C-fumarate delivery, fumarase clearance, and ma-
late production in CVD would facilitate clinical
translation. The MRI results presented here would be
strengthened by correlation with histology. Future
work should strive to identify the mechanism
resulting in persistent malate production 7 days after
MI; our results could be explained by the beginning of
low-level cardiomyocyte necrosis that is known to
occur during cardiac remodeling into failure (2), but
could also indicate accumulation and persistence of
released fumarase enzyme in the extracellular space.
Understanding how long fumarase persists after MI
will be essential in quantifying 13C-malate MRI signal
as a marker of necrosis. Furthermore, correlating
perfusion imaging techniques, such as ﬁrst pass
gadolinium or co-infusion with hyperpolarized
13C-urea (30), and 13C-fumarate imaging may enable
the 13C-fumarate images themselves to facilitate
interpretation of 13C-malate images in the context of
altered perfusion. Ultimately, the application of
13C-fumarate imaging in patients with prior MI or
coronary artery disease and comparison with current
well-established imaging techniques will determine
the value of this promising method.
CONCLUSIONS
Malate production in the infarcted heart appears to
provide a speciﬁc probe of necrosis acutely following
MI, and for at least 1 week afterwards. This technique
could offer a new noninvasive method to measure
cellular necrosis in heart disease, and warrants
further investigation in patients.
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PERSPECTIVES
COMPETENCY IN MEDICAL KNOWLEDGE: MR
measurement of the hyperpolarized 13C-fumarate to
13C-malate conversion showed an 82-fold increase 24 h
after an experimental MI (which persisted as a 31-fold
increase after 1 week). This metabolic conversion could be
imaged with a novel MRI pulse sequence, and correlated
positively with other markers of necrosis: cell membrane
integrity, wall motion abnormalities, and energetic
depletion. Hyperpolarized 13C-fumarate may be used as a
clinical MR tracer within several years, and could
potentially offer the ﬁrst method to noninvasively mea-
sure the rate and location of necrosis in CVD.
TRANSLATIONAL OUTLOOK: Pending development
of the clinical hyperpolarized 13C-fumarate tracer, future
basic science work should strive to characterize the rela-
tionships among necrosis, hyperpolarized 13C-fumarate
delivery, fumarase clearance, and malate production.
Furthermore, correlation with perfusion imaging tech-
niques may facilitate interpretation of 13C-malate images
in the context of altered perfusion.
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